MYRIAD GENETICS INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Myriad Genetics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2010 to Q1 2024.
  • Myriad Genetics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$8.8M, a 79.6% decline year-over-year.
  • Myriad Genetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $153M.
  • Myriad Genetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$8M, a 94.7% increase from 2021.
  • Myriad Genetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$151M, a 1406% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$8.8M -$3.9M -79.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 -$4.9M -$100K -2.08% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 -$4.8M +$43.7M +90.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 -$48.5M -$48.7M -24350% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 -$3.9M +$8.4M +68.3% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q1 2020 $200K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q3 2019 -$12.3M -$264M -105% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q3 2018 $252M +$275M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q3 2017 -$23.3M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q3 2013 -$102M -$64.4M -173% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q3 2012 -$37.1M -$17.8M -92.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q3 2011 -$19.3M -$3.79M -24.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q3 2010 -$15.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.